OOCYTE CRYOPRESERVATION MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-4068 |   Health Care

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Oocyte Cryopreservation Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL OOCYTE CRYOPRESERVATION MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL OOCYTE CRYOPRESERVATION MARKET

7.1 GLOBAL OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA OOCYTE CRYOPRESERVATION MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 Anova Fertility (Canada)

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Manchester Fertility (United Kingdom)

16.3 CCRM IVF (United States)

16.4 CREATE Fertility (United Kingdom)

16.5 Extend Fertility (United States)

16.6 Kindbody (United States)

16.7 HRC Fertility (United States)

16.8 London Women's Clinic (United Kingdom)

16.9 IVF Australia (Australia)

16.10 Prelude Fertility (United States)

16.11 Reproductive Biology Associates (United States)

16.12 Virtus Health (Australia)

16.13 Mayo Clinic (United States)

16.14 Pacific Fertility Center-Los Angeles (PFCLA) (United States)

16.15 Monash IVF (Australia)

16.16 Shady Grove Fertility (United States)

16.17 Melbourne IVF (Australia)

16.18 San Diego Fertility Center (SDFC) (United States)

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Slow-cooling Method
Flash-freezing Process (Vitrification)
By Application
25-30-Year-Old Female
30-35-Year-Old Female
35-40-Year-Old Female
Others
By Component
Cryopreservation Media
Cryopreservation Storage Devices (Dewars Cryogenic Liquid Cylinders Cryogenic Storage Tanks and Storage Container)
Consumables & Accessories
Cryo-Shipping

By End User
Biobanks
IVF & Fertility Clinics
Research & Academic Institutes
Cryo-shipping/couriers
Cryo Monitoring /Inventory Management

Companies

Anova Fertility (Canada)
Manchester Fertility (United Kingdom)
CCRM IVF (United States)
CREATE Fertility (United Kingdom)
Extend Fertility (United States)
Kindbody (United States)
HRC Fertility (United States)
London Women's Clinic (United Kingdom)
IVF Australia (Australia)
Prelude Fertility (United States)
Reproductive Biology Associates (United States)
Virtus Health (Australia)
Mayo Clinic (United States)
Pacific Fertility Center-Los Angeles (PFCLA) (United States)
Monash IVF (Australia)
Shady Grove Fertility (United States)
Melbourne IVF (Australia)
San Diego Fertility Center (SDFC) (United States)

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.